Literatur
-
1
Partridge A H, Ruddy K J.
Fertility and adjuvant treatment in young women with breast cancer.
Breast.
2007;
16
175-181
-
2
Warne G L, Fairley K F.
Cyclophosphamide induced ovarian failure.
N Engl J Med.
1973;
289
1159-1162
-
3
Chiarelle A M, Marret L D.
Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964–1988 in Ontario.
Canada Am J Epidemiol.
1999;
150
245-254
-
4
Byrne J, Fears T R, Gail M H.
Early menopause in long-term survivors of cancer during adolescence.
Am J Obst Gynecol.
1992;
166
788-793
-
5
Larsen E C, Müller J, Schmiegelow K.
Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer.
J Clin Endocrinol Metab.
2003;
88
5307-5314
-
6
Emig R, Wallwiener D, Licht P.
Ovarschutz und Fertilitätserhalt vor und während der Chemotherapie.
Geburtsh Frauenheilk.
2003;
63
574-576
-
7
Badawy A, Elnashar A, El-Ashry M et al.
Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.
Fertil Steril.
2008;
, [Epub ahead of print]
-
8
Blumenfeld Z, von Wolff M.
GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
Hum Reprod Update.
2008;
14
543-552
-
9
Sonmezer M, Oktay K.
Fertility preservation in young women undergoing breast cancer therapy.
The Oncologist.
2006;
11
422-434
-
10
Beck-Fruchter R, Weiss A, Shalec E.
GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data.
Hum Reprod Update.
2008;
14
553-561
-
11
Huang Y H, Zhao X J, Zhang Q H et al.
The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.
Gynecol Oncol.
2009;
112
409-414
-
12
von Wolff M, Thaler C, Frambach T et al.
Ovarian stimulation to cryopreserve fertilized oozytes in cancer patients can be started in the luteal phase.
Fertil Steril.
2008;
, [epub ahead of print]
-
13
von Otte S, Schöpper B, Al Hasani S.
In vitro Maturation. Eine Perspektive der assistierten Reproduktion.
Der Gynäkologe.
2004;
37
701-709
-
14
Azim A A, Costantini-Ferrando M, Lostritto K et al.
Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
J Clin Endocrinol Metab.
2007;
92
2197-2200
-
15
Trounson A O, Bongso A.
Fertilisation and development in humans.
Curr Top Dev Biol.
1996;
32
59-101
-
16
Cha K Y, Chung H M, Lim J M.
Freezing immature oocytes.
Mol Cell Endocrinol.
2000;
169
43-47
-
17
von Wolff M, Donnez J, Hovatta O et al.
Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy – a technique in its infancy but already successful in fertility preservation.
Eur J Cancer.
, [in press]
-
18
Blumfeld Z.
Gynecologic concerns for young women exposed to gonadotoxic chemotherapy.
Curr Opin Obst Gynecol.
2003;
15
359-370
-
19 von Wolff M. Fallvorstellungen. 2. Arbeitstreffen „FertiPROTEKT” Bonn 11 / 2006
-
20
Walshe J M, Denduluri N, Swain S.
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
J Clin Oncol.
2006;
24
5769-5779
Dr. med. B. Lawrenz
Universitäts-Frauenklinik Tübingen
Calwerstr. 7
72076 Tübingen
eMail: Barbara.Lawrenz@med.uni-tuebingen.de
